OpenURL Connection Search

Select item for more details and to access through your institution.

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Published in:
British Journal of Cancer, 2024, v. 130, n. 5, p. 788, doi. 10.1038/s41416-023-02525-2
By:
- Hogarty, Michael D.;
- Ziegler, David S.;
- Franson, Andrea;
- Chi, Yueh-Yun;
- Tsao-Wei, Denice;
- Liu, Kangning;
- Vemu, Rohan;
- Gerner, Eugene W.;
- Bruckheimer, Elizabeth;
- Shamirian, Anasheh;
- Hasenauer, Beth;
- Balis, Frank M.;
- Groshen, Susan;
- Norris, Murray D.;
- Haber, Michelle;
- Park, Julie R.;
- Matthay, Katherine K.;
- Marachelian, Araz
Publication type:
Article
Pilot study of intravenous melphalan combined with continuous infusion L- S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2015, v. 62, n. 10, p. 1739, doi. 10.1002/pbc.25594
By:
- Anderson, Clarke P.;
- Matthay, Katherine K.;
- Perentesis, John P.;
- Neglia, Joseph P.;
- Bailey, Howard H.;
- Villablanca, Judith G.;
- Groshen, Susan;
- Hasenauer, Beth;
- Maris, John M.;
- Seeger, Robert C.;
- Reynolds, C. Patrick
Publication type:
Article
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium.
Published in:
Pediatric Blood & Cancer, 2013, v. 60, n. 11, p. 1801, doi. 10.1002/pbc.24643
By:
- Maurer, Barry J.;
- Kang, Min H.;
- Villablanca, Judith G.;
- Janeba, Jitka;
- Groshen, Susan;
- Matthay, Katherine K.;
- Sondel, Paul M.;
- Maris, John M.;
- Jackson, Hollie A.;
- Goodarzian, Fariba;
- Shimada, Hiroyuki;
- Czarnecki, Scarlett;
- Hasenauer, Beth;
- Reynolds, C. Patrick;
- Marachelian, Araz
Publication type:
Article

Found: 3

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.

Pilot study of intravenous melphalan combined with continuous infusion L- S,R-buthionine sulfoximine for children with recurrent neuroblastoma.

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium.